CLLS Stock Summary and Trading Ideas (Cellectis S.A. - American Depositary Shares | NASDAQ:CLLS)

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

Cellectis S.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol CLLS.

As of April 15, 2024, CLLS stock price declined to $2.61 with 40,342 million shares trading.

CLLS has a beta of 6.52, meaning it tends to be more sensitive to market movements. CLLS has a correlation of 0.37 to the broad based SPY ETF.

CLLS has a market cap of $187.80 million. This is considered a Micro Cap stock.

Last quarter Cellectis S.A. - American Depositary Shares reported $2 million in Revenue and -$.36 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.06.

In the last 3 years, CLLS stock traded as high as $20.42 and as low as $.96.

The top ETF exchange traded funds that CLLS belongs to (by Net Assets): APIE, AVDE.

CLLS has outperformed the market in the last year with a price return of +27.3% while the SPY ETF gained +25.3%. However, in the short term, CLLS had mixed performance relative to the market. It has underperformed in the last 3 months, returning -9.7% vs +6.2% return in SPY. But in the last 2 weeks, CLLS shares have fared better than the market returning -1.5% compared to SPY -3.6%.

CLLS support price is $2.54 and resistance is $2.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLLS stock will trade within this expected range on the day.